scanX
Home
Hester Biosciences

Hester Biosciences

2,404.50
-48.75
(-1.99%)
Market Cap (₹ Cr.)
₹2,088
52 Week High
3,379.00
Book Value
₹343
52 Week Low
1,292.85
PE Ratio
107.88
PB Ratio
7.16
PE for Sector
57.62
PB for Sector
19.92
ROE
6.99 %
ROCE
11.55 %
Dividend Yield
0.24 %
EPS
₹22.75
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
12.07 %
Net Income Growth
-24.50 %
Cash Flow Change
103.94 %
ROE
-28.07 %
ROCE
3.30 %
EBITDA Margin (Avg.)
-12.76 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
26
25
24
25
29
31
30
29
35
29
39
32
38
39
43
42
50
44
42
45
42
39
54
53
63
60
58
55
51
52
74
72
62
81
68
66
74
75
Expenses
17
16
17
16
18
20
21
20
23
18
23
19
26
24
27
23
30
26
30
30
31
26
36
32
48
40
39
39
40
41
56
52
50
69
54
54
60
60
EBITDA
10
8
8
8
10
11
9
10
12
11
16
13
11
16
16
19
20
18
12
14
11
14
18
21
15
19
18
16
11
10
18
20
12
12
13
13
14
15
Operating Profit %
28 %
33 %
28 %
29 %
33 %
34 %
29 %
31 %
33 %
35 %
39 %
39 %
27 %
39 %
37 %
44 %
39 %
40 %
28 %
30 %
25 %
34 %
33 %
39 %
24 %
31 %
30 %
28 %
20 %
18 %
22 %
27 %
18 %
14 %
18 %
18 %
17 %
18 %
Depreciation
3
1
1
1
2
1
1
1
2
1
1
1
1
2
2
2
3
2
2
2
2
2
2
2
2
2
2
2
3
2
2
2
3
3
3
3
2
2
Interest
1
1
1
1
1
1
1
1
1
1
0
1
1
1
1
1
1
1
1
1
2
1
2
1
0
0
0
0
1
1
2
3
0
1
1
1
1
1
Profit Before Tax
5
6
6
6
7
9
7
8
9
9
14
11
9
13
14
16
16
15
9
11
7
10
14
18
13
17
16
14
7
7
14
14
9
9
9
9
10
11
Tax
2
1
2
1
2
3
0
2
2
2
5
3
1
4
4
5
3
5
2
3
2
3
4
5
5
5
4
4
2
2
4
3
2
2
2
2
3
3
Net Profit
4
5
4
5
6
6
6
6
7
6
9
7
9
10
10
12
12
10
9
8
5
8
10
13
9
12
12
11
5
5
10
11
6
6
7
6
7
8
EPS in ₹
4.16
5.48
5.05
5.59
6.47
7.05
7.04
6.84
8.32
7.23
10.41
7.64
10.60
11.38
11.68
13.94
14.55
11.52
10.22
9.09
5.88
8.96
11.90
15.62
10.41
14.38
13.84
12.41
5.82
5.88
12.16
12.61
7.36
7.61
7.97
7.61
8.74
9.91
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
140
159
178
210
240
277
282
424
546
550
Fixed Assets
57
62
61
67
101
96
87
84
108
103
Current Assets
53
67
75
89
99
123
140
166
216
204
Capital Work in Progress
14
10
21
30
0
1
4
82
149
171
Investments
0
0
9
14
28
41
44
65
65
65
Other Assets
70
87
88
99
111
139
148
194
224
210
Total Liabilities
56
59
56
64
61
74
44
156
253
237
Current Liabilities
35
37
34
42
39
58
35
75
136
98
Non Current Liabilities
21
21
22
22
22
16
10
81
117
139
Total Equity
84
100
122
146
179
203
238
268
292
313
Reserve & Surplus
76
92
114
138
171
195
229
260
284
304
Share Capital
9
9
9
9
9
9
9
9
9
9
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
3
1
6
-0
-9
3
-4
0
3
-2
Investing Activities
-12
-6
-15
-26
-25
-21
-4
-111
-72
-21
Operating Activities
20
19
28
32
36
26
41
16
33
43
Financing Activities
-5
-12
-6
-6
-20
-1
-41
95
41
-24
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
53.73 %
53.73 %
53.73 %
53.73 %
53.73 %
53.73 %
53.73 %
53.73 %
53.73 %
53.73 %
53.73 %
53.73 %
53.73 %
53.73 %
FIIs
0.60 %
0.58 %
0.68 %
0.80 %
0.92 %
0.72 %
0.00 %
0.45 %
0.45 %
0.45 %
0.42 %
0.43 %
0.43 %
0.52 %
DIIs
0.82 %
0.40 %
0.00 %
0.02 %
0.04 %
0.03 %
0.65 %
0.03 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
44.84 %
45.29 %
45.58 %
45.45 %
45.31 %
45.51 %
45.61 %
45.78 %
45.82 %
45.82 %
45.85 %
45.84 %
45.84 %
45.74 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Torrent Pharmaceuticals
3,359.60 1,16,815.97 69.82 10,785.75 11.59 1,656 20.90 47.50
Ajanta Pharma
3,121.15 39,351.06 46.09 4,293.31 11.77 816 18.09 49.72
Gland Pharma
1,841.50 30,430.47 42.14 5,834.96 50.97 772 -25.94 37.24
Eris Lifesciences
1,397.05 18,928.93 49.77 2,032.96 19.85 397 -4.52 62.53
Caplin Point Laboratories
1,965.50 15,241.11 31.91 1,761.04 15.65 461 19.85 57.70
Marksans Pharma
281.22 13,424.98 40.20 2,227.83 16.55 315 26.45 67.40
Shilpa Medicare
901.90 8,720.99 212.33 1,159.77 8.64 32 1,091.53 73.96
Jeena Sikho Lifecare
1,406.80 3,353.63 100.45 207.35 40.06 34 - 55.67
Amrutanjan Health Care
804.90 2,253.29 52.91 192.42 12.50 21 -34.09 56.41
Syncom Formulations
23.18 2,241.90 79.50 238.85 3.11 20 73.41 56.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
44.81
ATR(14)
Less Volatile
103.20
STOCH(9,6)
Neutral
31.97
STOCH RSI(14)
Overbought
83.11
MACD(12,26)
Bullish
7.71
ADX(14)
Weak Trend
12.94
UO(9)
Bearish
39.83
ROC(12)
Uptrend But Slowing Down
3.31
WillR(14)
Neutral
-72.48
Bearish
4
Neutral
4
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.